Abstract
We describe a case of chronic fatigue syndrome (CFS) associated to Parvovirus B19 infection where administration of intravenous immunoglobulins (IVIG), previously reported as effective, induced a paradoxical clinical response and increased viral replication. The indication of IVIG administration in the treatment of Parvovirus B19-associated CFS should be carefully reconsidered.
Keywords:
Chronic fatigue syndrome; Intravenous immunoglobulin therapy; Parvovirus B19.
Copyright © 2014 Elsevier B.V. All rights reserved.
Publication types
-
Case Reports
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adult
-
Antibodies, Viral
-
B-Lymphocytes / immunology
-
B-Lymphocytes / metabolism
-
DNA, Viral
-
Fatigue Syndrome, Chronic / diagnosis
-
Fatigue Syndrome, Chronic / etiology*
-
Fatigue Syndrome, Chronic / therapy*
-
Humans
-
Immunoglobulins, Intravenous / therapeutic use*
-
Lymphocyte Count
-
Male
-
Parvoviridae Infections / complications*
-
Parvoviridae Infections / diagnosis
-
Parvoviridae Infections / virology
-
Parvovirus B19, Human / classification*
-
Parvovirus B19, Human / genetics
-
Polymerase Chain Reaction
-
Treatment Outcome
-
Viral Load
Substances
-
Antibodies, Viral
-
DNA, Viral
-
Immunoglobulins, Intravenous